AMN director awarded 8,304 restricted stock units

Hinton James H. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hinton James H. reported acquisition or exercise transactions in this Form 4 filing.

AMN Healthcare Services director James H. Hinton received an equity award of 8,304 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMN common stock under the AMN Healthcare 2025 Equity Plan.

The RSUs were granted on May 1, 2026 and vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. At Hinton’s irrevocable election, the vested RSUs will settle in shares on the date he separates from service as a director.

Insider Trade Summary

Grant/Award: 8,304 shares

Grant/Award 1 txn

Insider Hinton James H.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	8,304	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 8,304 contracts (Direct)

Footnotes (3)

1. F1. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
2. F2. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.
3. F3. Restricted Stock Units do not have an expiration date.

Key Figures

RSUs granted: 8,304 units Underlying common shares: 8,304 shares Price per RSU: $0.00 +1 more

4 metrics

RSUs granted 8,304 units Grant of restricted stock units on May 1, 2026

Underlying common shares 8,304 shares Each RSU represents one share of AMN common stock

Price per RSU $0.00 Grant/award acquisition, no purchase price paid

RSUs held after grant 8,304 units Total restricted stock units following this transaction

Key Terms

Restricted Stock Units, AMN Healthcare 2025 Equity Plan, contingent right, Annual Meeting of Shareholders, +1 more

5 terms

Restricted Stock Units financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AMN Healthcare 2025 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

contingent right financial

"Each RSU represents a contingent right to receive one share of AMN Common Stock."

Annual Meeting of Shareholders financial

"vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

separation from service financial

"will settle on the date of the director's separation from service with the Company."

FAQ

What did AMN (AMN) director James H. Hinton receive in this Form 4 filing?

James H. Hinton received 8,304 restricted stock units (RSUs) of AMN common stock as an equity award. These RSUs were granted under the AMN Healthcare 2025 Equity Plan and represent a contingent right to receive one share of common stock per unit.

When do James H. Hinton’s 8,304 AMN RSUs vest according to the filing?

The 8,304 AMN RSUs vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders. This structure ties vesting to either time served or the next scheduled shareholder meeting.

How will the AMN (AMN) RSUs granted to James H. Hinton be settled?

The RSUs will settle in AMN common stock on the date of Hinton’s separation from service as a director, based on his irrevocable election. At that time, each vested RSU converts into one share of AMN common stock for delivery.

Do the restricted stock units granted to AMN director James H. Hinton have an expiration date?

The filing states that restricted stock units do not have an expiration date. Instead, they are governed by vesting and settlement conditions, including service-based vesting and settlement upon the director’s separation from service with AMN Healthcare.

Under which plan were the 8,304 AMN restricted stock units granted to James H. Hinton?

The 8,304 restricted stock units were granted under the AMN Healthcare 2025 Equity Plan. This plan authorizes equity-based awards such as RSUs to directors, with each unit representing a contingent right to receive one share of AMN common stock upon settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hinton James H.

(Last) (First) (Middle)

2999 OLYMPUS BLVD

(Street)

DALLAS TEXAS 75019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/01/2026		A		8,304		(2)	(3)	Common Stock	8,304	$0	8,304	D

Explanation of Responses:

1. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

2. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

3. Restricted Stock Units do not have an expiration date.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of James H. Hinton	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)